Role of Heme Oxygenase-1 in Cardiovascular Diseases: A Novel Target for Molecular Intervention?
- 1 October 2001
- journal article
- editorial
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 8 (5) , 444-446
- https://doi.org/10.1177/152660280100800503
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal AngioplastyJournal of Endovascular Therapy, 2001
- Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiencyAmerican Journal of Kidney Diseases, 2000
- Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Associated with Susceptibility to EmphysemaAmerican Journal of Human Genetics, 2000
- MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranesAmerican Journal of Physiology-Cell Physiology, 1999
- Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injuryJournal of Clinical Investigation, 1999
- Heme oxygenase–carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?Cardiovascular Research, 1999
- Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiencyJournal of Clinical Investigation, 1999
- Expression of heme oxygenase-1 can determine cardiac xenograft survivalNature Medicine, 1998
- Reduced stress defense in heme oxygenase 1-deficient cellsProceedings of the National Academy of Sciences, 1997